Meridian Bioscience Q4 Revenues Rise 6 Percent; MDx Business Continues to Grow | GenomeWeb

NEW YORK (GenomeWeb News) – Meridian Bioscience today said that its fiscal fourth-quarter sales rose 6 percent year over year with its molecular diagnostic business contributing to the growth.

For the three months ended Sept. 30, the company posted $43.7 million in revenues, compared to $41.3 million a year ago, beating the consensus analyst estimate of $43.0 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV. 

Mar
09
Sponsored by
Bio-Rad

This webinar will discuss how next-generation sequencing and digital PCR can be used in a complementary manner for liquid biopsies in order to improve patient care.